DISAPPEARANCE OF ANTI-DRUG ANTIBODIES TO INFLIXIMAB AND ADALIMUMAB AFTER ADDITION OF AN IMMUNOMODULATOR IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE

Anne Samira Strik  1     Gijs R. van den Brink  2     Cyriel Y. Ponsioen  3     Ron Mathôt  4     Mark Lowenberg  5     Geert R. D'Haens    
1 Academic Medical Centre, Gastroenterology, Amsterdam, Netherlands
2 Academisch Medisch Centrum, Dept. of Gastroenterology, Amsterdam, Netherlands
3 AMC Amsterdam Gastroenterology and Hepatology, Gastroenterology & Hepatology, Amsterdam, Netherlands
4 Academic Medical Centre, Pharmacy, Amsterdam, Netherlands
5 Academisch Medisch Centrum

Conference
UEG Week 2016

Citation
United European Gastroenterology Journal; 2016: 2 (Supplement 1)


Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Forgot your password?

Reset myUEG password

Social Sharing